Medical Management of Frontal Sinusitis

Maheep Sohal; Belachew Tessema; Seth M Brown

doi:10.1016/j.otc.2016.03.016

Medical Management of Frontal Sinusitis

Otolaryngol Clin North Am. 2016 Aug;49(4):927-34. doi: 10.1016/j.otc.2016.03.016. Epub 2016 Jun 18.

Authors

Maheep Sohal¹, Belachew Tessema², Seth M Brown³

Affiliations

¹ Division of Otolaryngology, Department of Surgery, University of Connecticut School of Medicine, Farmington, CT, USA.
² Division of Otolaryngology, Department of Surgery, University of Connecticut School of Medicine, Farmington, CT, USA; The Connecticut Sinus Institute, 21 South Road, Suite 112, Farmington, CT 06032, USA.
³ Division of Otolaryngology, Department of Surgery, University of Connecticut School of Medicine, Farmington, CT, USA; The Connecticut Sinus Institute, 21 South Road, Suite 112, Farmington, CT 06032, USA. Electronic address: sethmbrown@msn.com.

PMID: 27329981
DOI: 10.1016/j.otc.2016.03.016

Abstract

Rhinosinusitis is a term that has long been used to describe a diverse disease entity that encompasses several related but distinct conditions involving the paranasal sinuses. Frontal sinusitis represents one such entity with its own unique treatment considerations. Like rhinosinusitis as a whole, the role of medical management in the treatment of frontal sinusitis cannot be overlooked. Contemporary medical management of frontal sinusitis requires recognition of the unique disease process with implementation of targeted therapies aimed at addressing the specific pathophysiology.

Keywords: Frontal sinus; Medical management; Pharmacotherapy; Rhinosinusitis; Sinusitis.

Publication types

Review

MeSH terms

Adrenal Cortex Hormones / administration & dosage*
Anti-Bacterial Agents / therapeutic use*
Chronic Disease
Complementary Therapies / methods
Disease Management*
Frontal Sinusitis / drug therapy*
Humans
Paranasal Sinuses
Rhinitis / drug therapy*

Substances

Adrenal Cortex Hormones
Anti-Bacterial Agents